SCHEMBL21067912

SCHEMBL21067912

COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ PIK3CD O00329 19/20 1.00
▸ PIK3CA P42336 18/20 1.00
▸ PIK3CB P42338 18/20 1.00
▸ PIK3CG P48736 18/20 1.00
▸ PRKDC P78527 18/20 1.00
▸ ABL1 P00519 17/20 1.00
▸ EGFR P00533 17/20 1.00
▸ HCK P08631 17/20 1.00
▸ SRC P12931 17/20 1.00
▸ KDR P35968 17/20 1.00
▸ MTOR P42345 17/20 1.00
▸ EPHB4 P54760 17/20 1.00
▸ PI4KB Q9UBF8 13/20 1.00
▸ ITK Q08881 1/20 0.69
▸ BTK Q06187 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3603658 0.98 PIK3CD (1.00) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL3616908 0.91 EGFR (1.00) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL16655475 0.86 PIK3CD (0.84) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL16655570 0.85 PIK3CD (0.75) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL4827163 0.83 SRC (0.83) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL12105019 0.83 SRC (0.70) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL15087027 0.83 SRC (0.72) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL4826071 0.83 EGFR (0.81) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL23997152 0.81 LCK (0.69) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL16654231 0.81 PIK3CD (0.67) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210254056-A1 IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS CAMP4 THERAPEUTICS CORPORATION 2021-08-19 — — US disclosed
US-20190192691-A1 REGULATED BIOCIRCUIT SYSTEMS OBSIDIAN THERAPEUTICS, INC. 2019-06-27 — — US disclosed
Send feedback